The effect of platelet lysate fibrinogen on the functionality of MSCs in immunotherapy

Biomaterials

Volumn 34, Issue 32, 2013, Pages 7840-7850

  Copland, Ian B ^a   Garcia, Marco A ^b   Waller, Edmund K ^a   Roback, John D ^a   Galipeau, Jacques ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Fibrinogen; Mesenchymal stromal cell; Platelet; Regenerative medicine

Indexed keywords

EX VIVO EXPANSION; FETAL BOVINE SERUM; FIBRINOGEN; IMMUNE-MODULATING EFFECTS; MESENCHYMAL STROMAL CELLS; MITOGENIC PROPERTIES; PROTEIN PRODUCTION; REGENERATIVE MEDICINE;

CELL PROLIFERATION; FLOWCHARTING; IMAGE STORAGE TUBES; PLATELETS; T-CELLS;

CELL CULTURE;

FIBRINOGEN; INDOLEAMINE 2,3 DIOXYGENASE; PLATELET LYSATE FIBRINOGEN; UNCLASSIFIED DRUG;

ARTICLE; CELL PROLIFERATION; EX VIVO STUDY; HUMAN; HUMAN CELL; IMMUNOMODULATION; IMMUNOTHERAPY; MESENCHYMAL STROMA CELL; MOLECULAR INTERACTION; PRIORITY JOURNAL; STEM CELL EXPANSION; T LYMPHOCYTE; UPREGULATION;

BOVINAE;

EID: 84881026080     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2013.06.050     Document Type: Article

References (42)

1. Pittenger M.F., Mackay A.M., Beck S.C., Jaiswal R.K., Douglas R., Mosca J.D., et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999, 284(5411):143-147.
2. Kinnaird T., Stabile E., Burnett M.S., Lee C.W., Barr S., Fuchs S., et al. Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote invitro and invivo arteriogenesis through paracrine mechanisms. Circ Res 2004, 94(5):678-685.
3. Shi Y., Hu G., Su J., Li W., Chen Q., Shou P., et al. Mesenchymal stem cells: a new strategy for immunosuppression and tissue repair. Cell Res 2010, 20(5):510-518.
4. Kuznetsov S.A., Mankani M.H., Robey P.G. Effect of serum on human bone marrow stromal cells: exvivo expansion and invivo bone formation. Transplantation 2000, 70(12):1780-1787.
5. Spees J.L., Gregory C.A., Singh H., Tucker H.A., Peister A., Lynch P.J., et al. Internalized antigens must be removed to prepare hypoimmunogenic mesenchymal stem cells for cell and gene therapy. Mol Ther 2004, 9(5):747-756.
6. Selvaggi T.A., Walker R.E., Fleisher T.A. Development of antibodies to fetal calf serum with arthus-like reactions in human immunodeficiency virus-infected patients given syngeneic lymphocyte infusions. Blood 1997, 89(3):776-779.
7. Schallmoser K., Bartmann C., Rohde E., Reinisch A., Kashofer K., Stadelmeyer E., et al. Human platelet lysate can replace fetal bovine serum for clinical-scale expansion of functional mesenchymal stromal cells. Transfusion 2007, 47(8):1436-1446.
8. Sporn M.B., Roberts A.B. Transforming growth factor-beta. Multiple actions and potential clinical applications. JAMA 1989, 262(7):938-941.
9. Ross R., Bowen-Pope D.F., Raines E.W. Platelet-derived growth factor and its role in health and disease. Philos Trans R Soc Lond B Biol Sci 1990, 327(1239):155-169.
10. Bernardo M.E., Avanzini M.A., Ciccocioppo R., Perotti C., Cometa A.M., Moretta A., et al. Phenotypical/functional characterization of invitro-expanded mesenchymal stromal cells from patients with Crohn's disease. Cytotherapy 2009, 1-12.
11. Bieback K., Hecker A., Kocaomer A., Lannert H., Schallmoser K., Strunk D., et al. Human alternatives to fetal bovine serum for the expansion of mesenchymal stromal cells from bone marrow. Stem Cells 2009, 27(9):2331-2341.
12. Lange C., Cakiroglu F., Spiess A.N., Cappallo-Obermann H., Dierlamm J., Zander A.R. Accelerated and safe expansion of human mesenchymal stromal cells in animal serum-free medium for transplantation and regenerative medicine. JCell Physiol 2007, 213(1):18-26.
13. Flemming A., Schallmoser K., Strunk D., Stolk M., Volk H.D., Seifert M. Immunomodulative efficacy of bone marrow-derived mesenchymal stem cells cultured in human platelet lysate. JClin Immunol 2011, 31(6):1143-1156.
14. Abdelrazik H., Spaggiari G.M., Chiossone L., Moretta L. Mesenchymal stem cells expanded in human platelet lysate display a decreased inhibitory capacity on T- and NK-cell proliferation and function. Eur J Immunol 2011, 41(11):3281-3290.
15. Bernardo M.E., Avanzini M.A., Perotti C., Cometa A.M., Moretta A., Lenta E., et al. Optimization of invitro expansion of human multipotent mesenchymal stromal cells for cell-therapy approaches: further insights in the search for a fetal calf serum substitute. JCell Physiol 2007, 211(1):121-130.
16. Herrick S., Blanc-Brude O., Gray A., Laurent G. Fibrinogen. Int J Biochem Cell Biol 1999, 31(7):741-746.
17. Guo M., Sahni S.K., Sahni A., Francis C.W. Fibrinogen regulates the expression of inflammatory chemokines through NF-kappaB activation of endothelial cells. Thromb Haemost 2004, 92(4):858-866.
18. Harley S.L., Powell J.T. Fibrinogen up-regulates the expression of monocyte chemoattractant protein 1 in human saphenous vein endothelial cells. Biochem J 1999, 341(Pt 3):739-744.
19. Hodgkinson C.P., Patel K., Ye S. Functional toll-like receptor 4 mutations modulate the response to fibrinogen. Thromb Haemost 2008, 100(2):301-307.
20. Masamune A., Kikuta K., Watanabe T., Satoh K., Hirota M., Hamada S., et al. Fibrinogen induces cytokine and collagen production in pancreatic stellate cells. Gut 2009, 58(4):550-559.
21. Thacker R.I., Retzinger G.S. Adsorbed fibrinogen regulates the behavior of human dendritic cells in a CD18-dependent manner. Exp Mol Pathol 2008, 84(2):122-130.
22. Francois M., Copland I.B., Yuan S., Romieu-Mourez R., Waller E.K., Galipeau J. Cryopreserved mesenchymal stromal cells display impaired immunosuppressive properties as a result of heat-shock response and impaired interferon-gamma licensing. Cytotherapy 2012, 14(2):147-152.
23. Romieu-Mourez R., Francois M., Boivin M.N., Stagg J., Galipeau J. Regulation of MHC class II expression and antigen processing in murine and human mesenchymal stromal cells by IFN-gamma, TGF-beta, and cell density. JImmunol 2007, 179(3):1549-1558.
24. Romieu-Mourez R., Francois M., Boivin M.N., Bouchentouf M., Spaner D.E., Galipeau J. Cytokine modulation of TLR expression and activation in mesenchymal stromal cells leads to a proinflammatory phenotype. JImmunol 2009, 182(12):7963-7973.
25. Lee G., Arepally G.M. Anticoagulation techniques in apheresis: from heparin to citrate and beyond. JClin Apher 2012, 27(3):117-125.
26. Mollison P.L. The introduction of citrate as an anticoagulant for transfusion and of glucose as a red cell preservative. Br J Haematol 2000, 108(1):13-18.
27. Yeromonahos C., Marlu R., Polack B., Caton F. Antithrombin-independent effects of heparins on fibrin clot nanostructure. Arterioscler Thromb Vasc Biol 2012, 32(5):1320-1324.
28. Sorensen I., Susnik N., Inhester T., Degen J.L., Melk A., Haller H., et al. Fibrinogen, acting as a mitogen for tubulointerstitial fibroblasts, promotes renal fibrosis. Kidney Int 2011, 80(10):1035-1044.
29. Francois M., Romieu-Mourez R., Li M., Galipeau J. Human MSC suppression correlates with cytokine induction of indoleamine 2,3-dioxygenase and bystander M2 macrophage differentiation. Mol Ther 2012, 20(1):187-195.
30. Kilian O., Flesch I., Wenisch S., Taborski B., Jork A., Schnettler R., et al. Effects of platelet growth factors on human mesenchymal stem cells and human endothelial cells invitro. Eur J Med Res 2004, 9(7):337-344.
31. Gruber R., Karreth F., Kandler B., Fuerst G., Rot A., Fischer M.B., et al. Platelet-released supernatants increase migration and proliferation, and decrease osteogenic differentiation of bone marrow-derived mesenchymal progenitor cells under invitro conditions. Platelets 2004, 15(1):29-35.
32. Doucet C., Ernou I., Zhang Y., Llense J.R., Begot L., Holy X., et al. Platelet lysates promote mesenchymal stem cell expansion: a safety substitute for animal serum in cell-based therapy applications. JCell Physiol 2005, 205(2):228-236.
33. Ode A., Duda G.N., Glaeser J.D., Matziolis G., Frauenschuh S., Perka C., et al. Toward biomimetic materials in bone regeneration: functional behavior of mesenchymal stem cells on a broad spectrum of extracellular matrix components. JBiomed Mater Res A 2010, 95(4):1114-1124.
34. Kuhns D.B., Priel D.A., Gallin J.I. Induction of human monocyte interleukin (IL)-8 by fibrinogen through the toll-like receptor pathway. Inflammation 2007, 30(5):178-188.
35. Smiley S.T., King J.A., Hancock W.W. Fibrinogen stimulates macrophage chemokine secretion through toll-like receptor 4. JImmunol 2001, 167(5):2887-2894.
36. Szaba F.M., Smiley S.T. Roles for thrombin and fibrin(ogen) in cytokine/chemokine production and macrophage adhesion invivo. Blood 2002, 99(3):1053-1059.
37. Wang Y., Abarbanell A.M., Herrmann J.L., Weil B.R., Manukyan M.C., Poynter J.A., et al. TLR4 inhibits mesenchymal stem cell (MSC) STAT3 activation and thereby exerts deleterious effects on MSC-mediated cardioprotection. PLoS One 2010, 5(12):e14206.
38. Waterman R.S., Tomchuck S.L., Henkle S.L., Betancourt A.M. Anew mesenchymal stem cell (MSC) paradigm: polarization into a pro-inflammatory MSC1 or an immunosuppressive MSC2 phenotype. PLoS One 2010, 5(4):e10088.
39. Yagi H., Soto-Gutierrez A., Parekkadan B., Kitagawa Y., Tompkins R.G., Kobayashi N., et al. Mesenchymal stem cells: mechanisms of immunomodulation and homing. Cell Transplant 2010, 19(6):667-679.
40. Musso T., Gusella G.L., Brooks A., Longo D.L., Varesio L. Interleukin-4 inhibits indoleamine 2,3-dioxygenase expression in human monocytes. Blood 1994, 83(5):1408-1411.
41. Bassal N.K., Hughes B.P., Costabile M. Arachidonic acid and its COX1/2 metabolites inhibit interferon-gamma mediated induction of indoleamine-2,3 dioxygenase in THP-1 cells and human monocytes. Prostaglandins Leukot Essent Fatty Acids 2012, 87(4-5):119-126.
42. Hucke C., MacKenzie C.R., Adjogble K.D., Takikawa O., Daubener W. Nitric oxide-mediated regulation of gamma interferon-induced bacteriostasis: inhibition and degradation of human indoleamine 2,3-dioxygenase. Infect Immun 2004, 72(5):2723-2730.